Amarin Corp Plc (AMRN)

[amarinbullfromchicago]

Sorry just answered but will reclarify. Why did we not go past $23.5 after Ada or better than expected quarterly expectations a few weeks ago, even though we were there pre-aha in November? It’s all relative to current value, since the current price represents the sentiment towards the stock. It doesn’t have anything to do with long term value or potential.

If we were trading $6 pre September 24th results, we probably would have opened $15 instead of $12. It’s more supply and demand than anything.

I’m not saying we’ll hit $20 after approval. We could be trading $25 by then or $30, and we should still go up $1-3. But the way I look at it is it’s a binary event, and it’s hugely priced in to be accepted. The only long shot we’ve had vs the market so far was sep 24th, everything else has been much more priced in than most (even myself) thought. If the market though FDA wasn’t highly likely, we’d be trading $12-$15 with an $8-10 upside post acceptance. Instead, I think everyone expects it and we rally small after, then continually on good news and sales after that